Cannabis Global CBD report underscores need for low-dose clinical trials A detailed look at non-prescription cannabidiol in 9 countries reveals a regulatory hodgepodge outpaced by a wild west market Nick LabaSeptember 15, 2020
Cannabis Charlotte’s Web continues B2B decrease dulled by e-commerce gains Without meaningful opening of the economy, the company projects further flat to modest revenue growth Nick LabaSeptember 14, 2020
Analysis Aurora hopes new CEO can stop the bleeding The once-promising producer previewed impairment charges of $1.8B, termination of UFC deal, while appointing Miguel Martin head boss Nick LabaSeptember 8, 2020
Cannabis Company study suggests inhalation of CBD safer than ingestion Tetra Bio-Pharma's results relate to other findings that high doses of CBD can cause toxicity in the liver when ingested Nick LabaAugust 28, 2020
Analysis Rubicon Organics cuts down on losses in Q2 while investors bet big Its Simply Bare brand has been a hit with consumers, but can the firm translate quality product into profit? Yes, say analysts Nick LabaAugust 26, 2020
Cannabis Student athletes competing in Canada no longer tested for weed Grass is back on the menu for most of the country's college competitors Nick LabaAugust 24, 2020
Cannabis Industry mover: Sherry Boodram As she advances her own career, the chemist-turned-regulatory pro takes the Canadian cannabis industry with her Nick LabaAugust 19, 2020
Cannabis Supreme Cannabis nixes Wiz Khalifa brand, blames Health Canada The company reported a related $12.6M impairment charge in its Q3 2020 earnings Nick LabaAugust 17, 2020
Cannabis Supreme Cannabis debuts Hiway value brand Company says the new product line is targeted at 'frequent' consumers Nick LabaAugust 10, 2020
Cannabis Kiaro celebrates its new Commercial Drive store this BC Day The white-walled, wood-accented weed retail chain has opened another location in Vancouver Nick LabaJuly 31, 2020